Kim Lauper

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Josef S Smolen, Robert Landewé, Sytske Anne Bergstra et al. · Annals of the Rheumatic Diseases · 2022 · 1.6K citations · Full text

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration

Kim Lauper, Michele Iudici, Denis Mongin et al. · Annals of the Rheumatic Diseases · 2022 · 138 citations · Full text

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study

Natacha Madelon, Kim Lauper, Gautier Bréville et al. · Clinical Infectious Diseases · 2021 · 122 citations · Full text

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Delphine S. Courvoisier, Katerina Chatzidionysiou, Denis Mongin et al. · Lara D. Veeken · 2020 · 90 citations

Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab

Natacha Madelon, Nelli Heikkilä, Irène Sabater Royo et al. · JAMA Neurology · 2022 · 86 citations · Full text